Sohomoy
HER2 Antibodies Gain Momentum as Oncology Drug Development Accelerates
Continuous improvements in molecular diagnostics are strengthening the identification of HER2-positive cancers. Accurate biomarker testing helps healthcare professionals select appropriate treatment options for individual patients. Market Overview The HER2 Antibodies Market is expected to register a CAGR of 5.1% from 2025 to 2031. The market valuation is reported as US$ XX million...
47 Views